- Healthcare associated infections ×
February 22, 2019
Last year the Microbiology Society submitted a joint response with the Society for Applied Microbiology (SfAM) to the Health and Social Care Select Committee’s inquiry into antimicrobial resistance. On the 24th January 2019, the UK government launched its strategy to tackle antimicrobial resistance (AMR). In this blog we highlight key points in the UK AMR Strategy and research priorities.
January 22, 2019
Species within the genus Pseudomonas are amongst the most researched bacteria in the scientific community. Bacteria in this genus are widely used as model organisms in microbial research, and include a range of important species in fields such as plant pathogenicity, bioremediation, and environmental microbiology.
January 17, 2019
In 2017 the World Health Organisation (WHO) published the 12 Priority Pathogens. This list is a catalogue of the pathogens they believe pose the greatest threat to human health. The list draws attention to the growing incidence of antimicrobial resistance (AMR) evolving in bacteria, a development that is particularly worrying as genetic material can be passed between different species of bacteria, spreading resistance to life-saving antibiotics.
September 30, 2016
Last week, the ExCeL arena in London hosted New Scientist Live, a huge festival of science and technology. During the event the Microbiology Society collaborated with the Biochemical Society to organise a panel discussion about the problem of antimicrobial resistance (AMR) entitled ‘When A Scratch Can Kill’. We recorded the panel for the podcast, and Andy Day, our Public Affairs Intern tells us more about the event, below.
August 11, 2016
Every year, hundreds of millions of patients across the world are affected by Healthcare-associated Infections, according to estimates from the World Health Organization (WHO). These infections can result from a surgery, or from the use of a medical device like a catheter, for example, and cause significant mortality and economic losses.